Synergy CHC Corp. (SNYRQ)
SNYRQ is quoted over the counter, not listed on an exchange. Synergy CHC Corp. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-13.
Profile
| Field | Value |
|---|---|
| Ticker | SNYRQ, quoted over the counter |
| SEC CIK | 0001562733 |
| OTC Markets tier | Pink (price source, 2026-11-13) |
| SEC industry code | Medicinal Chemicals & Botanical Products |
| Business address | Westbrook, ME |
| Incorporated in | NV |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "Ordinarily, conditions or events that raise substantial doubt about an entity's ability to continue as a going concern relate to the entity's ability to meet its obligations as they become due." | 10-Q 2026-05-14 |
| Cash and burn | $292K cash; operating cash flow -$952K a quarter. | Report 2026-03-31 |
| Shares outstanding | 14,899,883 (2026-05-11); 9,014,110 a year earlier. | Cover page 2026-05-11 |
| Reverse splits, 3 years | 1; latest 1-for-11.9 on 2024-09-13 | Source 2024-09-13 |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the market | Latest 2025-12-09 |
| Exchange deficiency notices, 12 months | 3 (8-K item 3.01) | 8-K 2026-09-16 |
| Auditor | RBSM LLP, HOUSTON, Texas, United States | PCAOB Form AP 2026-04-01 |
| Late filings, 12 months | 1 NT notice | NT 10-K 2026-04-01 |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q1 2026 2026-03-31 | $5.5M | -$2.6M | -$2.0M | $292K | $25.0M | $27.7M | 10-Q 2026-05-14 |
| Q4 2025 2025-12-31 | $6.1M | -$14.8M | $624K | $2.6M | $25.2M | $30.4M | 10-K 2026-04-01 |
| Q3 2025 2025-09-30 | $8.0M | $125K | -$2.3M | $1.0M | $25.1M | $34.6M | 10-Q 2025-11-13 |
| Q2 2025 2025-06-30 | $8.1M | $1.5M | -$77K | $1.5M | $26.9M | $33.7M | 10-Q 2025-08-14 |
| Q1 2025 2025-03-31 | $8.2M | $876K | -$823K | $178K | $15.7M | $33.6M | 10-Q 2026-05-14 |
| Q4 2024 2024-12-31 | $10.3M | $106K | -$3.4M | $688K | $19.2M | $34.8M | 10-K 2026-04-01 |
| Q3 2024 2024-09-30 | $7.1M | $784K | -$237K | $259K | $7.0M | $37.8M | 10-Q 2025-11-13 |
| Q2 2024 2024-06-30 | $8.0M | $655K | -$282K | $187K | No debt tags | $41.5M | 10-Q 2025-08-14 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1 | 2026-05-15 |
| Latest annual report | 10-K | 2026-04-01 |
| Latest quarterly / interim | 10-Q | 2026-05-14 |
| Latest current report | 8-K | 2026-09-16 |
| Latest proxy | DEFA14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 252 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier